Corporate executives, the management consultants who advise them, and the financial industry executives who help corporations finance their capital investments tend to believe that whenever their ...

We often hear the words “value creator” and “business catalyst,” and depending who you speak with, they have different meanings and different impact. Processing Content A “value creator” is focused on ...

Roman Z. Matatov is with PKF O’Connor Davies, serving as a CFO for private business clients, and has a valuation and forensics background. In this four-part series of articles, I invite you to explore ...

A version of this article appeared in the Summer 2021 issue of strategy+business. In the blink of an eye, COVID-19 disrupted the business environment and illuminated a profound, sometimes overlooked ...

The Internal Rate of Return (IRR) has several well documented issues but remains the most commonly used measure of private market performance. One of the most commonly cited issues relates to how ...

The biotech IPO market in 2020 remains strong, despite the volatility and COVID headwinds. We’ve seen stellar pricings and good after-market performance, with ten new offerings already this year. And ...